New Membership to Help Accelerate Adoption of Semantic Web Standards In Commercial Products for Life Sciences R&D
SEATTLE, Wash. -- June 6, 2005 -- Teranode Corporation, the leading innovator of experiment design automation (XDA) software for the Life Sciences industry, today announced its membership to the World Wide Consortium (W3C). W3C is an international consortium where member organizations, staff, and the public work together to develop Web standards and lead the WWW to its full potential by developing protocols and guidelines that ensure long-term growth for the Web. Specifically, Teranode's membership is intended to establish meaningful collaborations with the Semantic Web for Life Sciences working group and accelerate implementation of standards in TERANODE XDA.
"Semantic Web standards, in combination with commercial products like TERANODE XDA, are essential to breaking bottlenecks associated with data access and data flow in Life Sciences," said Joseph Duncan, CEO of Teranode Corporation. "TERANODE XDA is an informatics platform that accelerates the availability and improves the quality of experiment data. Integrating Semantic Web standards as part of our platform will further increase the accessibility and mobility of this critical data."
Model-driven Informatics: Infrastructure for the Semantic Web
Discovery is challenged by constantly changing data requirements, increasing analytics complexity, and growing network of collaborators. The Semantic Web helps organizations to overcome these challenges. Until recently, companies have had only two choices on which to implement a Semantic Web: relational schemas and documents. Relational schemas provide scalability at a cost of expensive development, limited flexibility, and poor data mobility. Documents provide flexibility and mobility but are error-prone, labor intensive, and not searchable. TERANODE XDA offers a third form of infrastructure based on models that provides the scalability and reliability of relational schemas with the flexibility and mobility of documents. TERANODE XDA enhanced with RDF and other Semantic Web standards provide a flexible, scalable, and reliable data infrastructure for a Semantic Web in life science organizations.
For more about model-driven informatics, please see the IDC Life Science Insights white paper entitled, "Experiment Design Automation: A Potential Solution for Fragmented Informatics in Biopharmaceutical Research and Development." You can register for this report by going to: www.teranode.com/modeldriven.
About the World Wide Web Consortium (W3C)
The W3C was created to lead the Web to its full potential by developing common protocols that promote its evolution and ensure its interoperability. It is an international industry consortium jointly run by the MIT Computer Science and Artificial Intelligence Laboratory (MIT CSAIL) in the USA, and the European Research Consortium for Informatics and Mathematics (ERCIM), headquartered in France and Keio University in Japan. Services provided by the Consortium include: a repository of information about the World Wide Web for developers and users, and various prototype and sample applications to demonstrate use of new technology. To date, over 360 organizations are members of the Consortium. For more information on W3C, go to: www.w3.org/.
About Teranode Corporation
Teranode Corporation, headquartered in Seattle, WA, is the leading innovator of experiment design automation (XDA) software to improve speed and quality of experimentation for the benefit of accelerated R&D. The company, founded in 2002 to revolutionize the role that computing plays in Life Sciences, began with technologies invented by the founders at the University of Washington. TERANODE XDA is being used by leading pharmaceutical, biotechnology, research, and academic organizations including Pfizer, AstraZeneca, and Fred Hutchinson Cancer Research Center.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.